People are more health-conscious than ever before which is driving the growth of the global immune health supplement sector.

“Grandview Research reports that the immune health market size is expected to grow by 11.3 percent annually through 2028,” said Charles S. Cotropia, CEO of Enzolytics, Inc. “We realized that consumers want to be proactive about their health. They are especially seeking out immune health products, which is why Enzolytics developed IPF Immune™, a dietary supplement that supports the body’s self-defense system.”

Grandview Research listed a variety of factors that will spur the popularity of immune health supplements, including the increasing trend by consumers to invest in preventative supplements and their growing overall health awareness.

“Dietary supplement usage is at an all-time high according to the Council for Responsible Nutrition,” said Dr. Gaurav Chandra, Enzolytics’ COO. “Initial data from its 2022 annual survey on dietary supplement usage in the U.S. shows the number of American consumers buying supplements has reached the 80 percent level for the first time.”

Dr. Chandra said consumers are looking for products that will give their immune systems a boost.

“People today realize how important it is to keep your immune system operating at its optimum best,” he added. “IPF Immune™ is an incredible, natural, proprietary formula backed by science.

“Be proactive today about your immune system and your health. Include IPF Immune™ in your health regimen,” he added. “If you take care of your health now, you will have a more enjoyable life going forward.”

Mr. Cotropia said IPF Immune™, which is gluten-free, is a nutritional supplement that is taken orally two consecutive days per week for eight consecutive weeks.

Enzolytics is a Texas-based biotechnology company committed to developing effective and affordable therapeutics for treating a variety of conditions.

“The main job of our body’s innate immune system is to keep us healthy,” Mr. Cotropia said. “IPF Immune™ aids your immune system by supporting normal immune function.”

To purchase IPF Immune™, please visit OneLavi.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:
Enzolytics, Inc.
1101 Raintree Circle
Allen, Texas 75013
SOURCE: Enzolytics, Inc

About Enzolytics, Inc.

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.